Sodium Sulfacetamide And Sulfur Suspension
NDC Package 69367-245-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sodium Sulfacetamide And Sulfur suspension is sodium Sulfacetamide 8% and Sulfur 4% Topical Suspension is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. This formulation utilizes a suspension delivery system. Marketed by Westminster Pharmaceuticals, Llc, this product is identified by NDC 69367-245.

Identification & Billing

NDC Package Code
69367-245-16
Package Description
473 mL in 1 BOTTLE
Product Code
69367-245
11-Digit Billing Format
69367024516
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
473 ML
RxNorm Crosswalk
  • RxCUI: 1010234 - sulfacetamide sodium 8 % / sulfur 4 % Medicated Liquid Soap
  • RxCUI: 1010234 - sulfacetamide sodium 80 MG/ML / sulfur 40 MG/ML Medicated Liquid Soap
  • RxCUI: 1010234 - sulfacetamide sodium 8 % / sulfur 4 % Topical Suspension

Clinical Specifications

Proprietary Name
Sodium Sulfacetamide And Sulfur
Non-Proprietary Name
Sodium Sulfacetamide And Sulfur
Substance Name
Sulfacetamide Sodium; Sulfur
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Sodium Sulfacetamide 8% and Sulfur 4% Topical Suspension is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Regulatory & Marketing

Labeler Name
Westminster Pharmaceuticals, Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-18-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69367-245-16 identifies a specific commercial package of 473 ml in 1 bottle of Sodium Sulfacetamide And Sulfur, a human prescription drug labeled by Westminster Pharmaceuticals, Llc. This suspension is formulated for topical use and contains sulfacetamide sodium; sulfur as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Westminster Pharmaceuticals, Llc on June 18, 2021. The current certification is valid through December 31, 2026.

How is this Westminster Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69367024516. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69367-245-16
11-Digit CMS (5-4-2)
69367-0245-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.